Security Snapshot

DIVERSIFIED HEALTHCARE TRUST - Common Stock (DHC) Institutional Ownership

CUSIP: 25525P107

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

230

Shares (Excl. Options)

199,467,475

Price

$6.64

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
DHC on Nasdaq
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
199,467,475
Latest holder snapshot 5 signals
Total 13F value
$1,323,626,989
Portfolio coverage rank
0%
Share change
+9,690,443
Value change
+$75,210,955
Number of holders
230
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
239,663,265
SEC-reported price per share
$7.84
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • DHC - DIVERSIFIED HEALTHCARE TRUST - Common Stock is tracked under CUSIP 25525P107.
  • 230 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 217 to 230 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $920,675,194 to $1,323,626,989.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 230 institutions filings for Q1 2026.

Open SEC evidence

Security key

25525P107

Latest holder period

Q1 2026

13F holders

230

13D/G owners

1

CIK / CUSIP context first

Open Q1 2026 holders DHC full holder history DIVERSIFIED HEALTHCARE TRUST SEC filings DIVERSIFIED HEALTHCARE TRUST company facts DIVERSIFIED HEALTHCARE TRUST insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
DHC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flat Footed LLC 9.8% $53,550,360 23,487,000 Flat Footed LLC 30 Sep 2024

As of 31 Mar 2026, 230 institutional investors reported holding 199,467,475 shares of DIVERSIFIED HEALTHCARE TRUST - Common Stock (DHC). This represents 83% of the company’s total 239,663,265 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
72%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 10% 23,878,687 +3.8% 0% $158,554,481
Flat Footed LLC 9.8% 23,487,002 0% 52% $155,953,694
Silver Point Capital L.P. 6.5% 15,504,810 0% 7.9% $102,951,938
H/2 CREDIT MANAGER LP 6.2% 14,917,366 0% 20% $99,051,000
VANGUARD CAPITAL MANAGEMENT LLC 4% 9,599,703 0% 0% $63,742,028
STATE STREET CORP 3.7% 8,986,912 +35% 0% $59,673,096
VANGUARD PORTFOLIO MANAGEMENT LLC 3.7% 8,817,820 0% 0% $58,550,325
NOMURA HOLDINGS INC 3.1% 7,332,272 -29% 0.49% $48,686,286
GEODE CAPITAL MANAGEMENT, LLC 2.8% 6,608,497 +13% 0% $43,887,702
Davidson Kempner Capital Management LP 2.6% 6,247,830 0.89% $41,485,591
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2.5% 5,884,820 +15% 0.01% $39,075,205
CARRONADE CAPITAL MANAGEMENT, LP 2.2% 5,268,435 +11% 2.5% $34,982,000
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 2.1% 5,000,000 0% 0.05% $33,200,000
BlackBarn Capital Partners LP 2% 4,812,413 -26% 9.6% $31,954,422
CENTERSQUARE INVESTMENT MANAGEMENT LLC 1.2% 2,862,431 -11% 0.2% $19,006,541
JPMORGAN CHASE & CO 1.2% 2,773,388 +179% 0% $18,359,828
BANK OF AMERICA CORP /DE/ 1.1% 2,682,265 +90% 0% $17,810,239
DIMENSIONAL FUND ADVISORS LP 1% 2,399,804 +6.1% 0% $15,934,988
Bank of New York Mellon Corp 1% 2,390,413 +125% 0% $15,872,342
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.98% 2,354,824 +31% 0.01% $15,636,031
Park West Asset Management LLC 0.97% 2,327,403 +26% 1.4% $15,453,956
NORTHERN TRUST CORP 0.92% 2,199,273 +16% 0% $14,603,173
Hudson Bay Capital Management LP 0.84% 2,004,550 +0.23% 0.08% $13,310,212
T. Rowe Price Investment Management, Inc. 0.69% 1,648,707 0.01% $10,948,000
LONESTAR CAPITAL MANAGEMENT LLC 0.67% 1,600,000 -47% 5.7% $10,624,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
35
Latest
Q1 2026
Rows shown
1-25 of 35
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 199,467,475 $1,323,626,989 +$75,210,955 $6.64 230
2025 Q4 189,820,286 $920,675,194 +$17,551,155 $4.85 217
2025 Q3 183,160,026 $807,614,261 +$15,039,332 $4.41 203
2025 Q2 181,050,325 $648,055,814 -$12,470,705 $3.58 191
2025 Q1 182,800,749 $438,729,762 +$4,351,721 $2.40 201
2024 Q4 180,970,656 $416,202,988 -$2,602,765 $2.30 201
2024 Q3 179,546,607 $752,098,243 +$5,633,214 $4.19 189
2024 Q2 177,601,624 $541,684,983 -$8,228,518 $3.05 185
2024 Q1 180,309,025 $443,554,457 -$2,933,531 $2.46 183
2023 Q4 181,987,351 $680,602,394 +$14,507,339 $3.74 174
2023 Q3 177,489,077 $344,317,529 +$3,722,679 $1.94 173
2023 Q2 175,671,101 $395,272,756 +$10,154,671 $2.25 155
2023 Q1 180,997,912 $244,320,606 +$9,195,726 $1.35 163
2022 Q4 178,916,821 $115,727,033 -$13,695,274 $0.65 170
2022 Q3 193,840,853 $191,945,613 -$8,038,663 $0.99 189
2022 Q2 197,548,738 $359,548,284 +$4,389,019 $1.82 208
2022 Q1 196,544,574 $628,103,501 +$2,184,019 $3.20 209
2021 Q4 194,009,046 $599,369,915 +$5,083,336 $3.09 209
2021 Q3 186,844,183 $633,519,295 -$5,033,021 $3.39 195
2021 Q2 187,944,755 $788,346,904 -$9,149,417 $4.18 204
2021 Q1 189,469,082 $905,459,153 +$9,211,488 $4.78 206
2020 Q4 188,167,510 $775,023,156 +$6,099,072 $4.12 207
2020 Q3 181,157,744 $637,592,594 -$13,176,420 $3.52 221
2020 Q2 184,357,401 $815,558,212 +$36,191,091 $4.42 210
2020 Q1 176,988,200 $642,360,366 +$614,156,430 $3.63 223
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .